Given that our L2-IL-1β transgenic mice develop both BE/GEJ adenocarcinoma and ESCC, it provides the opportunity to further elucidate the differential molecular mechanisms driving these two distinct translationally relevant phenotypes that represent the two most common esophageal cancers in humans. This evidence concerns the gene IL1B and Barrett esophagus.